Ataxin-1 Activators
Ataxin-1 activators, as listed above, are primarily compounds that could potentially influence Ataxin-1 activity indirectly by modulating transcription, RNA processing, or broader cellular processes. These compounds do not directly interact with Ataxin-1 but affect the cellular environment and pathways related to its functions. Hsp90 inhibitors like 17-AAG and Geldanamycin might stabilize Ataxin-1, influencing its activity by affecting molecular chaperones. Histone deacetylase inhibitors (HDAC inhibitors) such as Sodium Butyrate, Trichostatin A, Vorinostat, and Valproic Acid could indirectly affect Ataxin-1 by altering chromatin structure and transcription regulation.
Curcumin and Resveratrol are known for their multiple effects on cellular signaling pathways and could have an indirect impact on Ataxin-1, particularly in the context of neuroprotection and transcription regulation. Rapamycin, as an mTOR inhibitor, and Bortezomib, a proteasome inhibitor, represent compounds that influence cellular growth, survival, and protein degradation pathways, which could indirectly modulate Ataxin-1 activity. RGFP966, a specific HDAC3 inhibitor, might also influence Ataxin-1's role in transcription regulation, albeit indirectly.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, an Hsp90 inhibitor, could potentially stabilize Ataxin-1 through its effect on molecular chaperones, indirectly influencing its activity. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin, another Hsp90 inhibitor, might also stabilize Ataxin-1 and indirectly affect its function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to interact with multiple signaling pathways and could indirectly modulate Ataxin-1's role in transcription and RNA metabolism. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium, often used in neurological disorders, might have an indirect effect on Ataxin-1 through its broad impact on cellular signaling pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, could indirectly influence Ataxin-1 activity by altering chromatin structure and transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA, similar to Sodium Butyrate, might impact Ataxin-1 function indirectly through modifications in chromatin accessibility and transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, may influence Ataxin-1's role in transcription regulation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, known for its neuroprotective effects, might indirectly affect Ataxin-1 function through various signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, could influence Ataxin-1 activity indirectly by affecting cellular growth and survival pathways. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, might have an indirect impact on Ataxin-1 through its effects on transcription regulation. | ||||||